Thymodepressin record · updated 6h ago

Healing & recoveryInflammation & immuneGrade C · preclinicalResearch use only

All 2 studies Jump to the evidence Compare

What is Thymodepressin used for?

Research peptide discovered via AI researcher. research peptide

Primarily researched for · Healing & recovery

Development stage

where Thymodepressin sits between preclinical work and regulatory approval

1Current
Preclinical
Animal / in-vitro work
2Not reached
Phase 1
Safety in humans
3Not reached
Phase 2
Efficacy signal
4Not reached
Phase 3
Confirmatory trials
5Not reached
Approved
Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 11 registered trials. It describes the research record, not a recommendation.

Identity

NameThymodepressin

Chain length—

Molecular weight333.3 Da

FormulaC16H19N3O5

Structure typeSmall molecule

ClassImmune

Research levelLimited Research

Discovered byThe Librarian · 2026

Mass and formula from PubChem CID 7275810. No verified residue count for this compound.

Pharmacology

Mechanism—

Route—

Half-life—

Time to peak—

Duration—

Extraction confidence—

Effect profile · 0–5

These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Aug 21, 2026. How this works →

Research stats

Total studies2

Human / animal / cellular0 / 2 / 0

Highest trial phasePreclinical

Years covered2026

Latest study1mo ago

Publication history

20262026

Research funding

—no NIH grants found

Safety signals

FAERS reportsnone recorded

Serious AEs in animal work—

Community reports—

Positive —Neutral —Negative —

Records

ChEMBL ClinicalTrials.gov DrugBank Google Scholar PubChem PubMed · 2 Semantic Scholar UniProt

Study register

2 rowsOpen in the library →

SortDate added ↓Publication year Evidence type Summary depth

Study	Type	Year	Summary depth
Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling. FindingNot reported in abstract.	Animal	2026	Full text read0.70
Exercise-specific plasma proteomic signatures in racehorses: Candidates for training adaptation and peak load monitoring. FindingNot reported in abstract.	Animal	2026	Full text read0.80

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Thymodepressin will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Thymodepressin is discussed should be drawn from it.